Cancer Gene Therapy Market Size, Share & Trends Analysis Report By Therapy (Oncolytic Virotherapy, Gene Induced Immunotherapy), By End-use (Research Institutes, Biopharmaceutical Companies), By Region, And Segment Forecasts, 2024 - 2030

Market Segmentation

• Cancer Gene Therapy by Therapy Outlook (Revenue, USD Million, 2018 - 2030)
  • Oncolytic Virotherapy
  • Gene Induced Immunotherapy
  • Gene Transfer
• Cancer Gene Therapy by End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Research Institutes
  • Biopharmaceutical Companies
  • Diagnostic Centers
  • Others
• Cancer Gene Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • North America Cancer Gene Therapy Market, By Therapy
      • Oncolytic Virotherapy
      • Gene Induced Immunotherapy
      • Gene Transfer
    • North America Cancer Gene Therapy Market, By End Use
      • Research Institutes
      • Biopharmaceutical Companies
      • Diagnostic Centers
      • Others
    • U.S.
      • U.S. Therapy Outlook (Revenue in USD Million, 2018-2030)
        • Oncolytic Virotherapy
        • Gene Induced Immunotherapy
        • Gene Transfer
      • U.S. End Use (Revenue in USD Million, 2018-2030)
        • Research Institutes
        • Biopharmaceutical Companies
        • Diagnostic Centers
        • Others
    • Canada
      • Canada Therapy Outlook (Revenue in USD Million, 2018-2030)
        • Oncolytic Virotherapy
        • Gene Induced Immunotherapy
        • Gene Transfer
      • Canada End Use (Revenue in USD Million, 2018-2030)
        • Research Institutes
        • Biopharmaceutical Companies
        • Diagnostic Centers
        • Others
    • Mexico
      • Mexico Therapy Outlook (Revenue in USD Million, 2018-2030)
        • Oncolytic Virotherapy
        • Gene Induced Immunotherapy
        • Gene Transfer
      • Mexico End Use (Revenue in USD Million, 2018-2030)
        • Research Institutes
        • Biopharmaceutical Companies
        • Diagnostic Centers
        • Others
  • Europe
    • Europe Cancer Gene Therapy Market, By Therapy
      • Oncolytic Virotherapy
      • Gene Induced Immunotherapy
      • Gene Transfer
    • Europe Cancer Gene Therapy Market, By End Use
      • Research Institutes
      • Biopharmaceutical Companies
      • Diagnostic Centers
      • Others
    • UK
      • UK Therapy Outlook (Revenue in USD Million, 2018-2030)
        • Oncolytic Virotherapy
        • Gene Induced Immunotherapy
        • Gene Transfer
      • UK End Use (Revenue in USD Million, 2018-2030)
        • Research Institutes
        • Biopharmaceutical Companies
        • Diagnostic Centers
        • Others
    • Germany
      • Germany Therapy Outlook (Revenue in USD Million, 2018-2030)
        • Oncolytic Virotherapy
        • Gene Induced Immunotherapy
        • Gene Transfer
      • Germany End Use (Revenue in USD Million, 2018-2030)
        • Research Institutes
        • Biopharmaceutical Companies
        • Diagnostic Centers
        • Others
    • Switzerland
      • Switzerland Therapy Outlook (Revenue in USD Million, 2018-2030)
        • Oncolytic Virotherapy
        • Gene Induced Immunotherapy
        • Gene Transfer
      • Switzerland End Use (Revenue in USD Million, 2018-2030)
        • Research Institutes
        • Biopharmaceutical Companies
        • Diagnostic Centers
        • Others
  • Asia Pacific
    • Asia Pacific Cancer Gene Therapy Market, By Therapy
      • Oncolytic Virotherapy
      • Gene Induced Immunotherapy
      • Gene Transfer
    • Asia Pacific Cancer Gene Therapy Market, By End Use
      • Research Institutes
      • Biopharmaceutical Companies
      • Diagnostic Centers
      • Others
    • Japan
      • Japan Therapy Outlook (Revenue in USD Million, 2018-2030)
        • Oncolytic Virotherapy
        • Gene Induced Immunotherapy
        • Gene Transfer
      • Japan End Use (Revenue in USD Million, 2018-2030)
        • Research Institutes
        • Biopharmaceutical Companies
        • Diagnostic Centers
        • Others
    • China
      • China Therapy Outlook (Revenue in USD Million, 2018-2030)
        • Oncolytic Virotherapy
        • Gene Induced Immunotherapy
        • Gene Transfer
      • China End Use (Revenue in USD Million, 2018-2030)
        • Research Institutes
        • Biopharmaceutical Companies
        • Diagnostic Centers
        • Others
    • Australia
      • Australia Therapy Outlook (Revenue in USD Million, 2018-2030)
        • Oncolytic Virotherapy
        • Gene Induced Immunotherapy
        • Gene Transfer
      • Australia End Use (Revenue in USD Million, 2018-2030)
        • Research Institutes
        • Biopharmaceutical Companies
        • Diagnostic Centers
        • Others
  • Rest of World
    • Rest of World Cancer Gene Therapy Market, By Therapy
      • Oncolytic Virotherapy
      • Gene Induced Immunotherapy
      • Gene Transfer
    • Rest of World Cancer Gene Therapy Market, By End Use
      • Research Institutes
      • Biopharmaceutical Companies
      • Diagnostic Centers
      • Others

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance